TITLE

"Liberation" death

AUTHOR(S)
Collier, Roger
PUB. DATE
August 2011
SOURCE
CMAJ: Canadian Medical Association Journal;8/9/2011, Vol. 183 Issue 11, pE723
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the death of Canadian woman, who underwent experimental multiple sclerosis therapy called liberation treatment, developed by Italian neurologist Paolo Zamboni.
ACCESSION #
67139066

 

Related Articles

  • Ms. Liberation July. Stevenson, Trisha // New Mobility;Feb2011, Vol. 22 Issue 209, p40 

    The article presents the author's knowledge about the diagnosis and treatment of mysterious symptoms (MS) illness based on her experiences. She mentions the most heavily promoted first-line disease modifying therapies for MS. She features Dr. Paolo Zamboni, director of the vascular disease...

  • The rise of people power. Chafe, Roger; Born, Karen B.; Slutsky, Arthur S.; Laupacis, Andreas // Nature;4/28/2011, Vol. 472 Issue 7344, p410 

    In this article, the authors discuss the impact of social media in research to improve treatment of multiple sclerosis (MS) in Canada. The authors mention the theory of Paolo Zamboni, a vascular surgeon from the University of Ferrara in Italy, on the new cause of MS which Zamboni called chronic...

  • Angioplasty Could Be a Future MS Treatment.  // Radiology Today;Apr2011, Vol. 12 Issue 4, p16 

    The article reports on the possibility that angioplasty might be a treatment for patients with multiple sclerosis (MS). It mentions that Italian physician Paolo Zamboni has published a study which shows that if angioplasty can widen blood vessels, then it could help lessen the severity of...

  • "Media, politics and science policy: MS and evidence from the CCSVI Trenches". Pullman, Daryl; Zarzeczny, Amy; Picard, André // BMC Medical Ethics;2013, Vol. 14 Issue 1, p1 

    Background: In 2009, Dr. Paolo Zamboni proposed chronic cerebrospinal venous insufficiency (CCSVI) as a possible cause of multiple sclerosis (MS). Although his theory and the associated treatment ("liberation therapy") received little more than passing interest in the international scientific...

  • Multiple Sclerosis - A Vascular Etiology? Weir, Bryce // Canadian Journal of Neurological Sciences;Nov2010, Vol. 37 Issue 6, p745 

    From the earliest pathological studies the perivenular localization of the demyelination in multiple sclerosis (MS) has been observed. It has recently been suggested that obstructions to venous flow or inadequate venous valves in the great veins in the neck, thorax and abdomen can cause damaging...

  • CCSVI: New Hope for MS? Savoie, Yves // Abilities;Summer2010, Issue 82, p42 

    The article offers information on the research on chronic cerebrospinal venous insufficiency (CCVI) by the Italian researcher Paolo Zamboni. It reports that it is a condition where the venous system does not sufficiently remove blood from the nervous system. Results indicated that the CCVI...

  • Disputing the Zamboni Effect in MS. Greb, Erik // Neurology Reviews;Jan2013, Vol. 21 Issue 1, p1 

    The article focuses on a study related to the correlation between the chronic cerebrospinal venous insufficiency (CCSVI), a term developed by Italian researcher Paolo Zamboni, and multiple sclerosis (MS). Under the study, 1,165 patients with MS, 226 with other neurological disorders and 376...

  • THE RISKS of 'LIBERATION'. Broverman, Aaron // New Mobility;Jul2010, Vol. 21 Issue 202, p19 

    The article discusses the move of the U.S. National MS Society and the MS Society of Canada to award research grants to anyone who wants to explore the viability of balloon angioplasty in treating people with multiple sclerosis (MS). It raises concerns on the theory developed by neurosurgeon...

  • Feds adopt wait-and-see strategy for funding of therapeutic clinical trial of liberation therapy for multiple sclerosis. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;10/5/2010, Vol. 182 Issue 14, pE676 

    The article reports on the wait-and-see strategic funding for the therapeutic clinical trial of the liberation therapy for multiple sclerosis (MS). It notes that the Canadian government will provide funding to Italian physician Paolo Zamboni on balloon venoplasty as a therapy for MS, given that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics